CG Oncology (CGON) Other Non Operating Income (2023 - 2026)
CG Oncology (CGON) posted Other Non Operating Income of -$101000.0 for Q1 2026, down 90.57% on a QoQ basis from -$53000.0 in Q4 2025, and down 2120.0% year-over-year from $5000.0 in Q1 2025.
CG Oncology (CGON) Other Non Operating Income (2023 - 2026) Analysis & Trends
CG Oncology's Other Non Operating Income history runs 4 years deep, the most recent figure standing at -$101000.0 for Q1 2026.
- Quarterly Other Non Operating Income fell 2120.0% year-over-year to -$101000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$258000.0 (down 1617.65% YoY) and the FY2025 annual result came in at -$152000.0, down 5166.67% from the prior year.
- Other Non Operating Income was -$101000.0 for Q1 2026 at CG Oncology, down from -$53000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $8000.0 in Q1 2023 and bottomed at -$101000.0 in Q1 2026.
- A 4-year average of -$24000.0 and a median of -$4000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income jumped 250.0% — and 2025, when it tumbled 4900.0%.
- CG Oncology's Other Non Operating Income stood at -$4000.0 in 2023, then soared by 250.0% to $6000.0 in 2024, then tumbled by 983.33% to -$53000.0 in 2025, then plunged by 90.57% to -$101000.0 in 2026.
- Business Quant data shows CGON's Other Non Operating Income at -$101000.0 in Q1 2026, -$53000.0 in Q4 2025, and -$100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | CG Oncology | 5.86 Bn | 5.86 Bn | -1.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -101,000.00 |
| Dec 31, 2025 | -53,000.00 |
| Sep 30, 2025 | -100,000.00 |
| Jun 30, 2025 | -4,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | -4,000.00 |
| Sep 30, 2023 | -8,000.00 |
| Jun 30, 2023 | -58,000.00 |
| Mar 31, 2023 | 8,000.00 |